Market Overview

FDA Says Amgen to Pay $762M to Resolve Criminal Liability

Related AMGN
Esperion Therapeutics Rockets 70% Higher After Big Selloff
Mid-Day Market Update: U.S. Stocks Turn Negative; AveXis Shares Spike Higher
Amgen's Humira Biosimilar Approved in Europe (GuruFocus)

View FDA page.

Posted-In: News FDA Legal


Related Articles (AMGN)

View Comments and Join the Discussion!